Amgen Inc. v. Amneal Pharmaceuticals LLC et al
| Amgen Inc. |
| Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. India Private Limited and Amneal Pharmaceuticals of New York LLC |
| 1:2016cv00925 |
| October 11, 2016 |
| US District Court for the District of Delaware |
| Wilmington Office |
| XX US, Outside State |
| Mitchell S Goldberg |
| Patent |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 8, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 34 CONSENT JUDGMENT. Signed by Judge Mitchell S. Goldberg on 9/8/2020. Associated Cases: 1:16-cv-00925-MSG, 1:16-cv-00853-MSG(nmg) |
| Filing 33 PROPOSED CONSENT JUDGMENT (Amneal Defendants) by Amgen Inc.. (Blumenfeld, Jack) |
| Filing 32 USCA Order (Federal Circuit) Terminating Appeals 2019-1650 and 2019-1770. USCA Decision: motion to voluntarily dismiss the above-captioned appeals pursuant to Fed. R. App. P. 42(b), with each side bearing its own fees and costs is GRANTED. Order issued as a mandate on 7/9/2020. (amf) |
Filing 31
ORDER of USCA. Decision of USCA: petitions for panel rehearing are denied; petition for rehearing en banc is denied. The mandate of the court will issue on April 22, 2020. (kmd)
|
| Filing 30 Letter to Counsel from Judge Goldberg regarding Delaware Case Assignments. (gvw) |
|
Filing 29
ORDER REASSIGNING CASE. Case reassigned to Judge Mitchell S. Goldberg, United States District Judge, United States District Court for the Eastern District of Pennsylvania, for all further proceedings. Judge Gregory M. Sleet no longer assigned to case. Signed by Judge Leonard P. Stark on 2/6/18. Associated Cases: 1:16-cv-00853-GMS et al.(gvw)
|
| CORRECTING ENTRY: The Notice of Service filed on March 2, 2017 has been removed from the docket, but remains in the Lead Case. ALL FUTURE FILINGS ARE TO BE MADE ONLY IN LEAD C.A. NO. 16-853 (GMS) Associated Cases: 1:17-cv-00113-GMS et al.(mdb) |
| Minute Entry for proceedings held before Judge Gregory M. Sleet - Scheduling Conference held on 2/23/2017. Discussion regarding the schedule and issues outlined in the joint status report. The court orders that these cases are consolidated for all purposes, including trial, without prejudice. All future filings are to be made ONLY in Lead C.A. No. 16-853 (GMS). There will be no summary judgment deadlines in the schedule. The Markman Hearing (1/2 day) is set for 5/22/2017 at 9:30 AM in Courtroom 4A; the Proposed Final Pretrial Order is due by the close of business on 1/29/2018; the Final Pretrial Conference is set for 2/15/2018 at 10:00 AM in Courtroom 4A; and a 7-day Bench Trial is set for 3/5/2018 at 9:00 AM in Courtroom 4A. The parties are given leave to amend the remaining deadlines in light of the assignment of these dates, and these cases are referred to the Magistrate Judge for exploring ADR. The plaintiff shall file the amended scheduling order by 3/6/2017, in the Lead Case only. (Court Reporter Kevin Maurer.) Associated Cases: 1:16-cv-00853-GMS et al.(mdb) |
| Remark - These cases have been consolidated for all purposes. All future filings shall be made ONLY in Lead C.A. No. 16-853 (GMS) (mdb) Associated Cases: 1:16-cv-00854-GMS et al.(mdb) |
| Filing 28 NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions Regarding Amneal filed by Amgen Inc..(Blumenfeld, Jack) |
| Filing 27 NOTICE OF SERVICE of Planitiff Amgen Inc.'s Responses and Objections to Defendants' First Requests for the Production of Documents and Things filed by Amgen Inc..(Blumenfeld, Jack) |
| Filing 26 NOTICE OF SERVICE of (1) Plaintiff's First Set of Requests to Amneal for the Production of Documents and Things and (2) Plaintiff's Second Set of Requests to Amneal for the Production of Documents and Things filed by Amgen Inc..(Noreika, Maryellen) |
|
ORAL ORDER - A Scheduling Conference is set for Thursday, February 23, 2017 at 10:00 AM (EST) in Courtroom 4A to discuss the contents of the Joint Status Report and Proposed Schedule. Ordered by Judge Gregory M. Sleet on 1/26/2017. Associated Cases: 1:16-cv-00853-GMS et al.(mdb)
|
| Filing 25 NOTICE OF SERVICE of Defendants' Production of Core Technical Documents Pursuant to Paragraph 4(b) of Delaware's Default Standard for Discovery [Highly Confidential-Outside Attorney's Eyes Only Pursuant to D. Del. LR 26.2] filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC.(Palapura, Bindu) |
| Filing 24 NOTICE OF SERVICE of (1) Plaintiff's Disclosures Pursuant to District of Delaware Default Standard Paragraph 3 and (2) Plaintiff's Rule 26(a)(1) Initial Disclosures filed by Amgen Inc..(Blumenfeld, Jack) |
| Filing 23 NOTICE OF SERVICE of Defendants' Rule 26(A)(1) Initial Disclosures; and Defendants' Disclosures Pursuant To Paragraph 3 Of The District Of Delawares Default Standard For Discovery Including Discovery Of Electronically Stored Information ("ESI") filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC.(Moore, David) |
|
SO ORDERED - re (24 in 1:16-cv-00854-GMS, 20 in 1:16-cv-00927-GMS, 22 in 1:16-cv-00900-GMS, 26 in 1:16-cv-00882-GMS, 19 in 1:16-cv-00853-GMS, 23 in 1:16-cv-00881-GMS, 22 in 1:16-cv-00855-GMS, 24 in 1:16-cv-00899-GMS, 20 in 1:16-cv-00928-GMS, 23 in 1:16-cv-00880-GMS, 21 in 1:16-cv-00926-GMS, 21 in 1:16-cv-00925-GMS) STIPULATION TO EXTEND TIME to serve Initial Disclosures Puruant to Fed. R. Civ. P. 26(a) and Pursuant to Paragrah 3 of Default Standard for Discovery to January 13, 2017 filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc. Ordered by Judge Gregory M. Sleet on 1/9/2017. Associated Cases: 1:16-cv-00882-GMS et al.(mdb)
|
| Filing 22 NOTICE OF SERVICE of Plaintiff's Default Standard 4(a) Disclosures filed by Amgen Inc..(Blumenfeld, Jack) |
| Filing 21 STIPULATION TO EXTEND TIME to serve Initial Disclosures Puruant to Fed. R. Civ. P. 26(a) and Pursuant to Paragrah 3 of Default Standard for Discovery to January 13, 2017 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc.. (Matterer, Mary) |
| Filing 20 NOTICE OF SERVICE of Defendants First Set of Requests for Production filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Matterer, Mary) |
| Filing 19 ANSWER to #18 Amended Answer to Complaint, Counterclaim by Amgen Inc..(Blumenfeld, Jack) |
| Filing 18 AMENDED ANSWER to #1 Complaint,, COUNTERCLAIM against Amgen Inc. by Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals LLC. (Palapura, Bindu) |
| Pro Hac Vice Attorney Kelsey J. Thorkelson for Amneal Pharmaceuticals LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Filing 17 Joint STATUS REPORT by Amgen Inc.. (Noreika, Maryellen) |
| Pro Hac Vice Attorney Jake M. Holdreith for Amneal Pharmaceuticals LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
|
SO ORDERED - re (15 in 1:16-cv-00928-GMS, 17 in 1:16-cv-00855-GMS, 16 in 1:16-cv-00899-GMS, 16 in 1:16-cv-00925-GMS, 13 in 1:16-cv-00853-GMS, 19 in 1:16-cv-00881-GMS, 19 in 1:16-cv-00854-GMS, 17 in 1:16-cv-00900-GMS, 20 in 1:16-cv-00882-GMS, 19 in 1:16-cv-00880-GMS, 16 in 1:16-cv-00926-GMS, 15 in 1:16-cv-00927-GMS) STIPULATION TO EXTEND TIME for the parties to submit the joint status report and proposed scheduling order to December 15, 2016 filed by Amgen Inc. Ordered by Judge Gregory M. Sleet on 12/12/2016. Associated Cases: 1:16-cv-00854-GMS et al.(mdb)
|
| Pro Hac Vice Attorney Oren D. Langer for Amneal Pharmaceuticals LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm) |
| Filing 16 STIPULATION TO EXTEND TIME for the parties to submit the joint status report and proposed scheduling order to December 15, 2016 - filed by Amgen Inc.. (Blumenfeld, Jack) |
|
SO ORDERED - re #15 MOTION for Pro Hac Vice Appearance of Attorney Oren D. Langer, Jake M. Holdreith and Kelsey J. Thorkelson of Robins Kaplan LLP filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC. Ordered by Judge Gregory M. Sleet on 12/8/2016. (mdb)
|
| Filing 15 MOTION for Pro Hac Vice Appearance of Attorney Oren D. Langer, Jake M. Holdreith and Kelsey J. Thorkelson of Robins Kaplan LLP - filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC. (Palapura, Bindu) |
| Filing 14 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amneal Pharmaceuticals Holding Company LLC, Corporate Parent Amneal Holdings, LLC for Amneal Pharmaceuticals LLC; Corporate Parent Amneal Pharmaceuticals LLC for Amneal Pharmaceuticals of New York LLC filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC. (Moore, David) |
| Filing 13 ANSWER to #1 Complaint, Defenses, and, COUNTERCLAIM against Amgen Inc. by Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals LLC.(Moore, David) Modified on 12/5/2016 (mdb). |
|
SO ORDERED - re #12 Stipulation and Order Regarding Voluntary Dismissal of Amneal Pharmaceuticals Co. India Private Limited Under Fed. R. Civ. P. 41(a) filed by Amgen Inc., Party Amneal Pharmaceuticals Co. India Private Limited terminated. Ordered by Judge Gregory M. Sleet on 11/22/2016. (mdb)
|
|
Filing 12
STIPULATION and Order Regarding Voluntary Dismissal of Amneal Pharmaceuticals Co. India Private Limited Under Fed. R. Civ. P. 41(a) by Amgen Inc.. (Noreika, Maryellen)
|
|
SO ORDERED - re (13 in 1:16-cv-00882-GMS, 12 in 1:16-cv-00926-GMS, 11 in 1:16-cv-00928-GMS, 9 in 1:16-cv-00927-GMS, 15 in 1:16-cv-00880-GMS, 16 in 1:16-cv-00854-GMS, 11 in 1:16-cv-00855-GMS, 14 in 1:16-cv-00900-GMS, 11 in 1:16-cv-00925-GMS, 12 in 1:16-cv-00881-GMS, 9 in 1:16-cv-00853-GMS) MOTION for Pro Hac Vice Appearance of Attorney Lois M. Kwasigroch and Wendy A. Whiteford filed by Amgen Inc. Ordered by Judge Gregory M. Sleet on 11/15/2016. Associated Cases: 1:16-cv-00853-GMS et al.(mdb)
|
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Lois M. Kwasigroch and Wendy A. Whiteford - filed by Amgen Inc.. (Noreika, Maryellen) |
|
SO ORDERED - re (10 in 1:16-cv-00855-GMS, 10 in 1:16-cv-00928-GMS, 8 in 1:16-cv-00853-GMS, 11 in 1:16-cv-00881-GMS, 9 in 1:16-cv-00899-GMS, 10 in 1:16-cv-00925-GMS, 15 in 1:16-cv-00854-GMS, 13 in 1:16-cv-00900-GMS, 14 in 1:16-cv-00880-GMS, 11 in 1:16-cv-00926-GMS, 8 in 1:16-cv-00927-GMS, 12 in 1:16-cv-00882-GMS) MOTION for Pro Hac Vice Appearance of Attorney John D. Murnane, Joshua I. Rothman and Alicia A. Russo of FITZPATRICK, CELLA, HARPER & SCINTO filed by Amgen Inc. Ordered by Judge Gregory M. Sleet on 11/9/2016. Associated Cases: 1:16-cv-00854-GMS et al.(mdb)
|
| Filing 10 MOTION for Pro Hac Vice Appearance of Attorney John D. Murnane, Joshua I. Rothman and Alicia A. Russo of FITZPATRICK, CELLA, HARPER & SCINTO - filed by Amgen Inc.. (Noreika, Maryellen) |
|
Filing 9
ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 11/2/2016. (asw)
|
| Filing 8 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to December 2, 2016 - filed by Amneal Pharmaceuticals Co. India Private Limited, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC. (Moore, David) |
|
SO ORDERED, re #8 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to December 2, 2016 filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals Co. India Private Limited, Set/Reset Answer Deadlines: Amneal Pharmaceuticals Co. India Private Limited answer due 12/2/2016; Amneal Pharmaceuticals LLC answer due 12/2/2016; Amneal Pharmaceuticals of New York LLC answer due 12/2/2016. Ordered by Judge Gregory M. Sleet on 11/2/2016. (asw)
|
| Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:16-cv-00925-GMS, 1:16-cv-00926-GMS, 1:16-cv-00927-GMS, 1:16-cv-00928-GMS (rjb) |
| Filing 7 SUMMONS Returned Executed by Amgen Inc.. Amneal Pharmaceuticals LLC served on 10/12/2016, answer due 11/2/2016. (Blumenfeld, Jack) |
| Filing 6 SUMMONS Returned Executed by Amgen Inc.. Amneal Pharmaceuticals of New York LLC served on 10/12/2016, answer due 11/2/2016. (Blumenfeld, Jack) |
| Summons Issued with Magistrate Consent Notice attached as to Amneal Pharmaceuticals Co. India Private Limited on 10/12/2016; Amneal Pharmaceuticals LLC on 10/12/2016; Amneal Pharmaceuticals of New York LLC on 10/12/2016. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (dmp, ) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Amgen Inc.. (dmp, ) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,375,405 B2;. (dmp, ) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/21/2016. Date of Expiration of Patent: 09/22/2026. Thirty Month Stay Deadline: N/A. (dmp, ) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Amneal Pharmaceuticals Co. India Private Limited, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-2010700.) - filed by Amgen Inc.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(dmp, ) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
